Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 28

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Is there a role for antibiotics in the treatment of chronic rhinosinusitis?

Smith, Stephanie Shintani, Kim, Raymond, Douglas, Richard · 2022 · Journal of Allergy and Clinical Immunology

Abstract

Rhinosinusitis is one of the most common reasons for adult outpatient antibiotic prescriptions, though there is little clinical evidence to support this practice, especially for chronic rhinosinusitis. Despite considerable research, the etiology of chronic rhinosinusitis, including the pathogenic role of microbes, remains poorly understood. Rigorous studies of the efficacy of antibiotic treatment of chronic sinusitis are surprisingly few in number and the results are somewhat conflicting. This article will review the rationales for and against the treatment of chronic rhinosinusitis with antibiotics, based on current evidence and understanding of pathophysiology, and will also summarize the current guidelines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2022.02.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 121

  1. Smith, 2013, National burden of antibiotic use for adult rhinosinusitis, J Allergy Clin Immunol, 132, 1230, 10.1016/j.jaci.2013.07.009 · DOI
  2. Garbutt, 2012, Amoxicillin for acute rhinosinusitis: a randomized controlled trial, JAMA, 307, 685, 10.1001/jama.2012.138 · DOI
  3. Meltzer, 2005, Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo, J Allergy Clin Immunol, 116, 1289, 10.1016/j.jaci.2005.08.044 · DOI · Paper page
  4. Merenstein, 2005, Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial, J Fam Pract, 54, 144
  5. Lindbaek, 1998, Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT, Rhinology, 36, 7
  6. Stalman, 1997, The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial, Br J Gen Pract, 47, 794
  7. van Buchem, 1997, Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis, Lancet, 349, 683, 10.1016/S0140-6736(96)07585-X · DOI · Paper page
  8. Kenealy, 2013, Antibiotics for the common cold and acute purulent rhinitis, Cochrane Database Syst Rev, 10.1002/14651858.CD000247.pub3 · DOI · Paper page
  9. Young, 2008, Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data, Lancet, 371, 908, 10.1016/S0140-6736(08)60416-X · DOI · Paper page
  10. Lindbaek, 1996, Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults, BMJ, 313, 325, 10.1136/bmj.313.7053.325 · DOI
  11. Hadley, 2010, Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis, Laryngoscope, 120, 1057, 10.1002/lary.20878 · DOI
  12. Fokkens, 2020, European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology, 58, 1, 10.4193/Rhin20.401 · DOI · Paper page
  13. Rudmik, 2016, Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study, Int Forum Allergy Rhinol, 6, 557, 10.1002/alr.21769 · DOI
  14. Orlandi, 2021, International consensus statement on allergy and rhinology: rhinosinusitis 2021, Int Forum Allergy Rhinol, 11, 213, 10.1002/alr.22741 · DOI · Paper page
  15. Liu, 2020, Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis, Allergy Asthma Immunol Res, 12, 176, 10.4168/aair.2020.12.2.176 · DOI
  16. Peters, 2014, Diagnosis and management of rhinosinusitis: a practice parameter update, Ann Allergy Asthma Immunol, 113, 347, 10.1016/j.anai.2014.07.025 · DOI · Paper page
  17. Hoggard, 2017, Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease, Clin Microbiol Rev, 30, 321, 10.1128/CMR.00060-16 · DOI
  18. Bhattacharyya, 2005, Bacterial infection in chronic rhinosinusitis: a controlled paired analysis, Am J Rhinol, 19, 544, 10.1177/194589240501900602 · DOI
  19. Wood, 2012, Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune response, Am J Rhinol Allergy, 26, 265, 10.2500/ajra.2012.26.3779 · DOI
  20. Kim, 2013, The interaction between bacteria and mucosal immunity in chronic rhinosinusitis: a prospective cross-sectional analysis, Am J Rhinol Allergy, 27, 183, 10.2500/ajra.2013.27.3974 · DOI
  21. Verderosa, 2019, Bacterial biofilm eradication agents: a current review, Front Chem, 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
  22. Vickery, 2019, The role of Staphylococcus aureus in patients with chronic sinusitis and nasal polyposis, Curr Allergy Asthma Rep, 19, 21, 10.1007/s11882-019-0853-7 · DOI
  23. Stewart, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
  24. Kern, 2008, Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis, Am J Rhinol, 22, 549, 10.2500/ajr.2008.22.3228 · DOI · Paper page
  25. Bachert, 2001, Total and specific IgE in nasal polyps is related to local eosinophilic inflammation, J Allergy Clin Immunol, 107, 607, 10.1067/mai.2001.112374 · DOI · Paper page
  26. Van Zele, 2004, Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis, J Allergy Clin Immunol, 114, 981, 10.1016/j.jaci.2004.07.013 · DOI · Paper page
  27. Bachert, 2010, Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma, J Allergy Clin Immunol, 126, 962, 10.1016/j.jaci.2010.07.007 · DOI · Paper page
  28. Feazel, 2012, Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis, Laryngoscope, 122, 467, 10.1002/lary.22398 · DOI · Paper page
  29. Hugenholtz, 2002, Exploring prokaryotic diversity in the genomic era, Genome Biol, 3, 10.1186/gb-2002-3-2-reviews0003 · DOI
  30. Biswas, 2015, The nasal microbiota in health and disease: variation within and between subjects, Front Microbiol, 9, 134, 10.3389/fmicb.2015.00134 · DOI · Paper page
  31. Hauser, 2015, Sinus culture poorly predicts resident microbiota, Int Forum Allergy Rhinol, 5, 3, 10.1002/alr.21428 · DOI
  32. Ramakrishnan, 2015, Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome, J Allergy Clin Immunol, 136, 334, 10.1016/j.jaci.2015.02.008 · DOI · Paper page
  33. Bassiouni, 2015, Sinonasal microbiome sampling: a comparison of techniques, PLoS One, 10, 10.1371/journal.pone.0123216 · DOI
  34. Gevaert, 2013, Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma, J Allergy Clin Immunol, 131, 110, 10.1016/j.jaci.2012.07.047 · DOI · Paper page
  35. Stevens, 2017, Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 5, 1061, 10.1016/j.jaip.2016.12.027 · DOI · Paper page
  36. Stevens, 2019, Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis, J Allergy Clin Immunol Pract, 7, 2812, 10.1016/j.jaip.2019.05.009 · DOI · Paper page
  37. Tan, 2017, Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois, J Allergy Clin Immunol, 139, 699, 10.1016/j.jaci.2016.06.063 · DOI
  38. Soler, 2013, Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations, Int Forum Allergy Rhinol, 3, 31, 10.1002/alr.21064 · DOI
  39. Tomassen, 2016, Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers, J Allergy Clin Immunol, 137, 1449, 10.1016/j.jaci.2015.12.1324 · DOI · Paper page
  40. Wang, 2016, Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania, J Allergy Clin Immunol, 138, 1344, 10.1016/j.jaci.2016.05.041 · DOI · Paper page
  41. Ryu, 2021, A survey on the management of chronic rhinosinusitis in the Korean Rhinologic Society, J Rhinol, 28, 44, 10.18787/jr.2020.00343 · DOI
  42. Lee, 2011, Regional and specialty variations in the treatment of chronic rhinosinusitis, Laryngoscope, 121, 1092, 10.1002/lary.21550 · DOI
  43. Fang, 2018, Antibiotic use patterns in endoscopic sinus surgery: a survey of the American Rhinologic Society membership, Int Forum Allergy Rhinol, 8, 522, 10.1002/alr.22085 · doi:10.1002/alr.22085
  44. Namyslowski, 2002, Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults, J Chemother, 14, 508, 10.1179/joc.2002.14.5.508 · DOI
  45. Legent, 1994, A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis, Chemotherapy, 40, 8, 10.1159/000239310 · DOI
  46. Hansen, 2019, Adverse events in people taking macrolide antibiotics versus placebo for any indication, Cochrane Database Syst Rev, 1
  47. Sadarangani, 2015, Non-anti-infective effects of antimicrobials and their clinical applications: a review, Mayo Clin Proc, 90, 109, 10.1016/j.mayocp.2014.09.006 · DOI
  48. Shimizu, 2016, Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan, Auris Nasus Larynx, 43, 131, 10.1016/j.anl.2015.08.014 · DOI
  49. Lechien, 2019, A 10-year follow-up of a randomized prospective study of 2 treatments for chronic rhinosinusitis without nasal polyps and investigation of the impact of gastroeosophageal reflux disease in the resistance to treatment, Ear Nose Throat J
  50. Lasso, 2017, Long-term low-dose macrolides for chronic rhinosinusitis in adults—a systematic review of the literature, Clin Otolaryngol, 42, 637, 10.1111/coa.12787 · DOI
  51. Spagnolo, 2013, Long-term macrolide treatment for chronic respiratory disease, Eur Respir J, 42, 239, 10.1183/09031936.00136712 · DOI
  52. Shimizu, 2003, In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells, Am J Respir Crit Care Med, 168, 581, 10.1164/rccm.200212-1437OC · DOI · Paper page
  53. Tamaoki, 1992, Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro, J Antimicrob Chemother, 29, 173, 10.1093/jac/29.2.173 · doi:10.1093/jac/29.2.173
  54. Takizawa, 1997, Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells, Am J Respir Crit Care Med, 156, 266, 10.1164/ajrccm.156.1.9612065 · DOI · Paper page
  55. Tateda, 2001, Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 45, 1930, 10.1128/AAC.45.6.1930-1933.2001 · DOI
  56. Yanagihara, 2002, Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model, J Antimicrob Chemother, 49, 867, 10.1093/jac/dkf013 · DOI
  57. Ehnhage, 2008, Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis, Int J Antimicrob Agents, 31, 561, 10.1016/j.ijantimicag.2008.01.027 · doi:10.1016/j.ijantimicag.2008.01.027
  58. Margaritis, 2007, Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis, Am J Rhinol, 21, 574, 10.2500/ajr.2007.21.3071 · doi:10.2500/ajr.2007.21.3071
  59. Fang, 2009, Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis, Int J Antimicrob Agents, 34, 67, 10.1016/j.ijantimicag.2009.01.014 · doi:10.1016/j.ijantimicag.2009.01.014
  60. Siu, 2020, Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trial, Xenobiotica, 50, 1443, 10.1080/00498254.2020.1814973 · DOI · Paper page
  61. Sabino, 2017, Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial, Int Forum Allergy Rhinol, 7, 135, 10.1002/alr.21846 · DOI
  62. Huck, 1993, Cefaclor vs amoxicillin in the treatment of acute, recurrent, and chronic sinusitis, Arch Fam Med, 2, 497, 10.1001/archfami.2.5.497 · DOI
  63. Amini, 2009, A comparing study of clarithromycin XL with co-amoxiclav for treatment of chronic sinusitis: a clinical trial, Iran J Clinic Infect Dis, 4, 197
  64. Fan, 2014, High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis, J Laryngol Otol, 128, 236, 10.1017/S0022215114000279 · DOI
  65. Jareoncharsri, 2004, An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients, Rhinology, 42, 23
  66. Namysłowski, 1998, Randomized clinical trial comparing the efficacy and safety of Augmentin versus cefuroxime in the treatment of chronic sinusitis in adult patients, Med Sci Monit, 4, PI551
  67. Head, 2016, Systemic and topical antibiotics for chronic rhinosinusitis, Cochrane Database Syst Rev, 4
  68. Wallwork, 2006, A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis, Laryngoscope, 116, 189, 10.1097/01.mlg.0000191560.53555.08 · DOI · Paper page
  69. Videler, 2011, Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial, Allergy, 66, 1457, 10.1111/j.1398-9995.2011.02693.x · DOI · Paper page
  70. Oakley, 2017, The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP), Curr Allergy Asthma Rep, 17, 30, 10.1007/s11882-017-0696-z · DOI
  71. Dubin, 2007, Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics, Ann Allergy Asthma Immunol, 98, 32, 10.1016/S1081-1206(10)60856-3 · DOI
  72. Sreenath, 2015, A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of “maximal medical therapy” for chronic rhinosinusitis, Int Forum Allergy Rhinol, 5, 820, 10.1002/alr.21542 · DOI
  73. Pinto Bezerra Soter, 2017, Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps, Rhinology, 55, 175, 10.4193/Rhino15.291 · DOI
  74. Lemiengre, 2012, Antibiotics for clinically diagnosed acute rhinosinusitis in adults, Cochrane Database Syst Rev, 10
  75. Ahovuo-Saloranta, 2014, Antibiotics for acute maxillary sinusitis in adults, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD000243.pub3 · DOI
  76. Sharp, 2007, Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002, Arch Otolaryngol Head Neck Surg, 133, 260, 10.1001/archotol.133.3.260 · DOI
  77. Kaszuba, 2006, Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists, Am J Rhinol, 20, 186, 10.1177/194589240602000214 · DOI
  78. Dubin, 2007, American Rhinologic Society member survey on “maximal medical therapy” for chronic rhinosinusitis, Am J Rhinol, 21, 483, 10.2500/ajr.2007.21.3047 · DOI
  79. Lund, 2005, Maximal medical therapy for chronic rhinosinusitis, Otolaryngol Clin N Am, 38, 1301, 10.1016/j.otc.2005.07.003 · doi:10.1016/j.otc.2005.07.003
  80. Fokkens, 2007, European position paper on rhinosinusitis and nasal polyps 2007, Rhinology Supplement, 20, 1
  81. Fokkens, 2012, European Position Paper on Rhinosinusitis and Nasal Polyps 2012, Rhinol Suppl, 23, 3
  82. Berkhout, 2013, Importance of bacteriology in upper airways of patients with cystic fibrosis, J Cyst Fibros, 12, 525, 10.1016/j.jcf.2013.01.002 · DOI
  83. Oomen, 2012, Sinonasal manifestations in cystic fibrosis, Int J Otolaryngol, 2012, 10.1155/2012/789572 · DOI
  84. Johansen, 2012, Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response, J Cyst Fibros, 11, 525, 10.1016/j.jcf.2012.04.011 · DOI
  85. Lim, 2014, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis, J Clin Microbiol, 52, 425, 10.1128/JCM.02204-13 · DOI
  86. Price, 2013, Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation, Microbiome, 1, 27, 10.1186/2049-2618-1-27 · DOI · Paper page
  87. Briaud, 2019, Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells, Sci Rep, 9, 16564, 10.1038/s41598-019-52975-z · DOI
  88. Bonestroo, 2010, Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways, J Cyst Fibros, 9, 130, 10.1016/j.jcf.2010.01.001 · DOI
  89. Mainz, 2009, Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis, Thorax, 64, 535, 10.1136/thx.2008.104711 · DOI · Paper page
  90. Psaltis, 2007, Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis, Laryngoscope, 117, 1302, 10.1097/MLG.0b013e31806009b0 · DOI · Paper page
  91. Clement, 2005, Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis, J Infect Dis, 192, 1023, 10.1086/432735 · DOI · Paper page
  92. Kim, 2015, Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity, Int Forum Allergy Rhinol, 5, 380, 10.1002/alr.21431 · doi:10.1002/alr.21431
  93. Bacci, 2020, Taxonomic variability over functional stability in the microbiome of cystic fibrosis patients chronically infected by Pseudomonas aeruginosa, bioRxiv
  94. Whelan, 2017, Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis, PLoS One, 12, 10.1371/journal.pone.0172811 · DOI
  95. Wagner Mackenzie, 2021, Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study, Respir Res, 22, 106, 10.1186/s12931-021-01697-w · DOI
  96. Karanth, 2019, Medical interventions for chronic rhinosinusitis in cystic fibrosis, Cochrane Database Syst Rev, 10
  97. Mainz, 2014, Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study, Drug Des Devel Ther, 8, 209, 10.2147/DDDT.S54064 · DOI
  98. Harvey, 2009, Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis, Immunol Allergy Clin North Am, 29, 689, 10.1016/j.iac.2009.07.006 · DOI
  99. Cervin, 2005, Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis, Otolaryngol Clin North Am, 38, 1339, 10.1016/j.otc.2005.08.002 · DOI
  100. Jaffe, 1998, Long-term azithromycin may improve lung function in children with cystic fibrosis, Lancet, 351, 420, 10.1016/S0140-6736(05)78360-4 · DOI · Paper page
  101. Cho, 2019, Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa, Am J Rhinol Allergy, 33, 129, 10.1177/1945892418815615 · DOI
  102. Comegna, 2021, Elexacaftor-tezacaftor-ivacaftor therapy for cystic dibrosis patients with the F508del/unknown genotype, Antibiotics (Basel), 10, 828, 10.3390/antibiotics10070828 · DOI
  103. Shah, 2018, Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review, Int Forum Allergy Rhinol, 8, 729, 10.1002/alr.22082 · DOI
  104. Harvey, 2008, Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation, Otolaryngol Head Neck Surg, 139, 137, 10.1016/j.otohns.2008.04.020 · DOI · Paper page
  105. Goddard, 2017, Effects of endoscopic sinus surgery and device on irrigation, Otolaryngol Head Neck Surg, 139, P75
  106. Uren, 2008, Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis, Laryngoscope, 118, 1677, 10.1097/MLG.0b013e31817aec47 · doi:10.1097/mlg.0b013e31817aec47
  107. Jervis-Bardy, 2012, A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis, Laryngoscope, 122, 2148, 10.1002/lary.23486 · DOI
  108. Carr, 2016, Alteration in bacterial culture after treatment with topical mupirocin for recalcitrant chronic rhinosinusitis, JAMA Otolaryngol Head Neck Surg, 142, 138, 10.1001/jamaoto.2015.3059 · DOI
  109. Jervis-Bardy, 2012, Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery, Int Forum Allergy Rhinol, 2, 111, 10.1002/alr.20106 · DOI
  110. Kisiel, 2020, Development of bacterial resistance during treatment with topical gentamicin for chronic rhinosinusitis in patients with cystic fibrosis and primary ciliary dyskinesis. Retrospective case series, Otolaryngol Pol, 74, 33, 10.5604/01.3001.0013.7851 · doi:10.5604/01.3001.0013.7851
  111. Aanaes, 2021, Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery, Acta Otolaryngol, 141, 181, 10.1080/00016489.2020.1841909 · doi:10.1080/00016489.2020.1841909
  112. Cho, 2019, In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms, Int Forum Allergy Rhinol, 9, 486, 10.1002/alr.22285 · doi:10.1002/alr.22285
  113. Hill, 2000, The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions, J Hosp Infect, 45, 198, 10.1053/jhin.2000.0733 · DOI
  114. Jeronimo, 2020, Effects of povidone-iodine composite on the elimination of bacterial biofilm, Int Forum Allergy Rhinol, 10, 884, 10.1002/alr.22568 · doi:10.1002/alr.22568
  115. Daood, 2020, A quaternary ammonium silane antimicrobial triggers bacterial membrane and biofilm destruction, Sci Rep, 10, 10970, 10.1038/s41598-020-67616-z · DOI
  116. Gaurav, 2020, Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia, Int J Antimicrob Agents, 56, 10.1016/j.ijantimicag.2020.106022 · DOI
  117. Kamel, 2012, Preoperative skin antiseptic preparations for preventing surgical site infections: a systematic review, Infect Control Hosp Epidemiol, 33, 608, 10.1086/665723 · doi:10.1086/665723
  118. Jervis-Bardy, 2009, Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery, Am J Rhinol Allergy, 23, 549, 10.2500/ajra.2009.23.3366 · doi:10.2500/ajra.2009.23.3366
  119. Jiang, 2008, Postoperative antibiotic care after functional endoscopic sinus surgery, Am J Rhinol, 22, 608, 10.2500/ajr.2008.22.3241 · doi:10.2500/ajr.2008.22.3241
  120. Albu, 2010, Prophylactic antibiotics in endoscopic sinus surgery: a short follow-up study, Am J Rhinol Allergy, 24, 306, 10.2500/ajra.2010.24.3475 · doi:10.2500/ajra.2010.24.3475
  121. Zhang, 2014, Culture-inappropriate antibiotic therapy decreases quality of life improvement after sinus surgery, Int Forum Allergy Rhinol, 4, 403, 10.1002/alr.21277 · DOI

Cited by

See all 28

Metadata

Authors
Smith, S. S., Kim, R., & Douglas, R.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2022-05
Volume
149
Issue
5
Pages
1504-1512
ISSN
0091-6749
Cited by
28
References
8
Language
en
Licence
Funders
  • National Institute of Allergy and Infectious Diseases (U19 AI106683)
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.